Stephens Detection of New Adverse Drug Reactions

Key text for all those involved in pharmacovigilance.
Detection of new adverse drug reactions is fundamental to the protection of patients from harm that may occur as a result of medication. This book explores the methods used to investigate new adverse drug reactions, discussing all elements from the scientific background and animal toxicology through to worldwide regulatory and ethical issues.
Stephens’ Detection of New Adverse Drug Reactions provides comprehensive, in–depth, up–to–date coverage of material fundamentally important to all those active in the field, whether they work in the pharmaceutical industry, drug regulatory authorities or in academia.
The fifth edition of this classic reference work includes new chapters on:vaccine safety surveillancemanaging drug safety issues with marketed productsoperational aspects of drug safety functionsafety of biotechnology productsfuture of pharmacovigilance
Reviews of previous editions:
"This book surpasses all its educational aims. Not only is the subject matter covered comprehensively but the material is presented in a very user–friendly manner. The editors have succeeded in producing a highly–specific, definitive reference book which doubles as a most enjoyable read."
—Comended by the 1999 BMA Medical Book Competition
"For anyone entering the field of adverse reaction monitoring one could not wish for a better primer"
—International Journal of Risk and Safety in Medicine

Spis treści:
Foreword.
Preface.
List of Contributors.
1. Introduction (M. Stephens).
2. Adverse Drug Reaction and Interactions: Mechanisms, Risk Factors, Detection, Management and Prevention (P. Routledge).
3. Toxicology and Adverse Drug Reactions (D. Snodin).
4. Clinical Trials: Collection of Safety Data and Establishing the Adverse Drug Reaction Profile (J. Talbot & #38;amp; M. Stephens).
5. Clinical Laboratory Safety Data in Drug Studies (A. Craig).
6. Statistics: Analysis and Presentation of Safety Data (S. Evans).
7. Causality and Correlation in Pharmacovigilance (S. Shakir).
8. Managing Drug Safety Issues with Marketed Products (P. Waller & H. Tilson).
9. Regulatory Aspects of Pharmacovigilance (B. Arnold).
10. Legal Aspects of Pharmacovigilance (C. Bendall).
11. Operational Aspects of the Drug Safety Function within a Pharmaceutical Company (J. Steiner).
12. Dictionaries and Coding in Pharmacovigilance (E. Brown).
13. Safety of Biotechnology Products (B. Brown and M. Westland).
14. Vaccine Safety Surveillance (E. Miller).
15. Ethical Issues in Drug Safety (M. Stephens).
16. A Model for the Future Conduct of Pharmacovigilance (P. Waller and S. Evans).
Appendix I.
Appendix II.
Bibliography.
Index.

Okładka tylna:
Key text for all those involved in pharmacovigilance.
Detection of new adverse drug reactions is fundamental to the protection of patients from harm that may occur as a result of medication. This book explores the methods used to investigate new adverse drug reactions, discussing all elements from the scientific background and animal toxicology through to worldwide regulatory and ethical issues.
Stephens’ Detection of New Adverse Drug Reactions provides comprehensive, in–depth, up–to–date coverage of material fundamentally important to all those active in the field, whether they work in the pharmaceutical industry, drug regulatory authorities or in academia.
The fifth edition of this classic reference work includes new chapters on:vaccine safety surveillancemanaging drug safety issues with marketed productsoperational aspects of drug safety functionsafety of biotechnology productsfuture of pharmacovigilance
Reviews of previous editions:
"This book surpasses all its educational aims. Not only is the subject matter covered comprehensively but the material is presented in a very user–friendly manner. The editors have succeeded in producing a highly–specific, definitive reference book which doubles as a most enjoyable read."
—Comended by the 1999 BMA Medical Book Competition
"For anyone entering the field of adverse reaction monitoring one could not wish for a better primer"
—International Journal of Risk and Safety in Medicine